China Pharma Holdings (CPHI) Change in Taxes (2010 - 2020)
China Pharma Holdings (CPHI) posted Change in Taxes of -$155827.0 for Q3 2020, down 168.57% on a QoQ basis from $227245.0 in Q2 2020, and down 332.74% year-over-year from $66953.0 in Q4 2019.
China Pharma Holdings (CPHI) Change in Taxes (2010 - 2020) Analysis & Trends
China Pharma Holdings' Change in Taxes history runs 11 years deep, the most recent figure standing at -$155827.0 for Q3 2020.
- Quarterly Change in Taxes fell 332.74% year-over-year to -$155827.0 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $113571.0 (up 1315.18% YoY) and the FY2019 annual result came in at $12971.0, up 108.82% from the prior year.
- Change in Taxes was -$155827.0 for Q3 2020 at China Pharma Holdings, down from $227245.0 in the prior quarter.
- Across five years, Change in Taxes topped out at $227245.0 in Q2 2020 and bottomed at -$163335.0 in Q1 2018.
- A 5-year average of $4244.9 and a median of -$10350.0 in 2019 frame the typical range for Change in Taxes.
- Annual changes were most pronounced in 2017 — Change in Taxes plunged 413.54% — and 2020, when it jumped 2655.49%.
- China Pharma Holdings' Change in Taxes stood at $146187.0 in 2016, then plunged by 88.35% to $17034.0 in 2017, then sank by 291.78% to -$32667.0 in 2018, then surged by 68.32% to -$10350.0 in 2019, then plunged by 1405.57% to -$155827.0 in 2020.
- Business Quant data shows CPHI's Change in Taxes at -$155827.0 in Q3 2020, $227245.0 in Q2 2020, and $52503.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 73.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -411.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -463.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 119.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -155,827.00 |
| Sep 30, 2020 | -155,827.00 |
| Jun 30, 2020 | 227,245.00 |
| Jun 30, 2020 | 227,245.00 |
| Mar 31, 2020 | 52,503.00 |
| Mar 31, 2020 | 52,503.00 |
| Dec 31, 2019 | -10,350.00 |
| Dec 31, 2019 | -10,350.00 |
| Sep 30, 2019 | 66,953.00 |
| Sep 30, 2019 | 66,953.00 |
| Jun 30, 2019 | 8,247.00 |
| Jun 30, 2019 | 8,247.00 |
| Mar 31, 2019 | -51,879.00 |
| Mar 31, 2019 | -51,879.00 |
| Dec 31, 2018 | -32,667.00 |
| Dec 31, 2018 | -32,667.00 |
| Sep 30, 2018 | -20,016.00 |
| Sep 30, 2018 | -20,016.00 |
| Jun 30, 2018 | 68,919.00 |
| Jun 30, 2018 | 68,919.00 |